英语翻译
"Although the company was well capitalized,we felt that additional resources would allow us to more aggressively execute our
hiring plan for 2008," commented Tillman Gerngross,Ph.D.,Chief Executive Officer of Adimab."We have also accelerated our
high throughput antibody expression and fermentation program,which is now expected to come on line in the second quarter of
this year.Upon completion,we will be able to go from antigen to a panel of fully human antibodies in less than ninety
days."
"We have seen many antibody discovery platforms and felt that Adimab has the most compelling and seamless offering," said
Michael Ross,Ph.D.,Managing Partner,SV Life Sciences."Adimab has assembled a great team,has a thorough understanding of
the IP,has made excellent progress on its technology,and has generated strong interest from several partners."
"Tillman runs a lean team,but they consistently set high expectations and then over-deliver," says Terry McGuire,Managing
General Partner of Polaris Ventures."The speed at which Adimab assembled a word class antibody discovery team and
implemented its business strategy was impressive."
在线翻译的不要发到这里
我有50分